our model assumes a 25% annual attrition rate, and that lapsed patients regain about two-thirds of the weight lost. Household impacts While survey data focuses on people taking obesity medicines, we could see a greater change to food consumption if the behavioral changes affect people in AOM patients households or social circles, speculates Morgan Stanley
The B12 injection uses a different mechanism of absorption and does not interact with GLP-1 pharmacokinetics
Allegations in lawsuits People who took Ozempic are suing the drug makers
With the new 7.2mg dose, 1 in 3 patients have been shown to lose up to 25% of their starting weight The Wegovy injection was also found, on average, to reduce: The numbers from these studies are from people taking Wegovy alongside a diet and exercise plan
Higher doses correlate with a greater likelihood of side effects
Does the clinic handle complaints well